NEWS
Institutional Subscription: Comprehensive Analyses to Enhance Your Global and Local Impact
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Mark Harrison
University of Oxford - Oxford / United Kingdom
History, Philosophy, Theology / History
AD Scientific Index ID: 1284544
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Mark Harrison's MOST POPULAR ARTICLES
1-)
Public Health in British India: Anglo-Indian Preventive Medicine 1859-1914M HarrisonCambridge University Press, 19946051994
2-)
Practice TestsM Harrison, R KerrOxford University Press, 19995751999
3-)
The economics of World War II: six great powers in international comparisonM HarrisonCambridge University Press, 20003592000
4-)
Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label …G Middleton, P Silcocks, T Cox, J Valle, J Wadsley, D Propper, F Coxon, ...The Lancet Oncology 15 (8), 829-840, 20144092014
5-)
Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trialSJ Dutton, DR Ferry, JM Blazeby, H Abbas, A Dahle-Smith, W Mansoor, ...The lancet oncology 15 (8), 894-904, 20143382014
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept